WVE
Wave Life Sciences Ltd.
$6.38
+0.06 (+0.95%)
At close · Jul 7
Market Cap
$1.23B
Shares
192,353,438
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$42.73M
-60.5%
FY2025
Net Income
-$204.38M
-110.7%
FY2025
Operating Margin
-504.09%
-402.2pp
FY2025
Diluted EPS
-$1.21
-72.9%
FY2025
Operating Cash Flow
-$187.49M
-24.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $42.73M | $108.3M | $113.31M | $3.65M | $40.96M | $20.08M | $15.98M | $14.41M | $3.7M | $1.49M | $152K | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $86K | -$12K | -$111K | |
| $189.6M | $182.78M | $159.68M | $130.01M | $115.86M | $121.88M | $130.94M | $175.43M | $134.43M | $79.31M | $40.82M | $9.06M | $2.4M | $1.92M | |
| $79.08M | $75.33M | $59.02M | $51.29M | $50.51M | $46.11M | $42.51M | $48.87M | $39.51M | $26.98M | $15.99M | $10.39M | $3M | $1.65M | |
| — | — | — | — | — | — | — | — | — | $2.16M | $784K | $594K | $281K | $276K | |
| $268.68M | $258.11M | $218.71M | $181.3M | $166.37M | $167.98M | $173.45M | $224.3M | $173.94M | $106.28M | $56.81M | $19.45M | $5.39M | $3.57M | |
| -$196.88M | -$215.38M | -$110.4M | -$68M | -$162.72M | -$127.02M | -$153.38M | -$208.32M | -$159.52M | -$102.39M | -$55.72M | -$19.3M | -$5.39M | -$3.57M | |
| — | -504.09% | -101.94% | -60.01% | -4459.3% | -310.07% | -763.94% | -1303.37% | -1106.72% | -2764.34% | -3752.19% | -12696.05% | — | — | |
| — | — | — | — | — | — | — | — | — | -$100.24M | -$54.94M | -$18.7M | -$5.11M | -$3.3M | |
| $13.29M | $11.01M | $13.4M | $9.81M | $1.58M | $4.57M | $2.63M | $14.68M | $12.94M | $1.25M | $542K | $142K | $249K | -$74K | |
| -$183.59M | -$204.38M | -$97.01M | -$58.19M | -$161.14M | -$122.45M | -$150.75M | -$193.64M | -$146.58M | -$101.14M | -$55.18M | -$19.16M | -$5.15M | -$3.65M | |
| $0 | $0 | $0 | -$677K | $681K | -$204K | -$841K | $0 | $69K | $842K | $482K | $44K | $84K | -$330K | |
| -$183.59M | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M | -$149.91M | -$193.64M | -$146.65M | -$101.98M | -$55.66M | -$19.2M | -$5.23M | -$3.32M | |
| — | -478.33% | -89.57% | -50.76% | -4434.72% | -298.42% | -746.68% | -1211.52% | -1017.43% | -2753.24% | -3748.15% | -12631.58% | — | — | |
| -$183.64M | -$204.37M | -$97.15M | -$57.61M | -$162.03M | -$122.45M | -$149.79M | -$193.52M | -$146.62M | -$101.57M | -$55.99M | -$19.22M | -$5.4M | -$3.18M | |
| USD/shares | — | -$1.21 | -$0.70 | -$0.54 | -$2.05 | -$2.36 | — | — | — | — | — | — | — | — |
| USD/shares | — | -$1.21 | -$0.70 | -$0.54 | -$2.05 | -$2.36 | — | — | — | — | — | — | — | — |
| shares | — | 168.65M | 138.28M | 106.1M | 78.86M | 51.83M | 39.23M | 33.87M | 28.97M | 26.51M | 22.8M | 10.5M | 3.91M | 1.74M |
| shares | — | 168.65M | 138.28M | 106.1M | 78.86M | 51.83M | 39.23M | 33.87M | 28.97M | 26.51M | 22.8M | 10.5M | 3.91M | 1.74M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.